1382469-17-1

Basic information

• Product Name: C₂₈H₄₇BN₂O₈
• Synonyms: C₂₈H₄₇BN₂O₈
• CAS NO: 1382469-17-1
• Molecular Weight: 550.501
• Mol File: 1382469-17-1.mol

Chemical Properties

• CAS DataBase Reference: C₂₈H₄₇BN₂O₈(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₈H₄₇BN₂O₈(1382469-17-1)
• EPA Substance Registry System: C₂₈H₄₇BN₂O₈(1382469-17-1)

Safety Data

• Hazardous Substances Data: 1382469-17-1(Hazardous Substances Data)

Upstream product

• 1382469-16-0 C₂₂H₃₅BrN₂O₆ 
• 73183-34-3 bis(pinacol)diborane 
• 20469-65-2 1-bromo-3,5-dimethoxybenzene 
• 106120-04-1 5-bromoresorcinol 

Downstream Products

• 1613643-87-0 C₅₆H₇₈N₄O₁₂ 
• 1613643-78-9 C₄₂H₅₈N₄O₈ 
• 1448256-62-9 C₂₇H₃₄N₄O₂ 

Relevant articles and documents

Role of amphiphilicity in the design of synthetic mimics of antimicrobial peptides with gram-negative activity

Two new series of aryl SMAMPs (synthetic mimics of antimicrobial peptides) with facially amphiphilic (FA) and disrupted amphiphilic (DA) topologies were designed and synthesized to directly assess the role of amphiphilicity on their antimicrobial activity

POLYCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

The present disclosure provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, malaria, mucositis, an ophthalmic infection, an otic infection, a cancer, or a Mycobacterium infection; killing or inhibiting the growth of a Plasmodium species; inhibiting the growth of a Mycobacterium species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin/low molecular weight heparin derivative.

CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

The present invention provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, mucositis, an ophthalmic infection, an otic infection, a cancer, or a Mycobacterium infection; inhibiting the growth of a Mycobacterium species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin/low molecular weight heparin derivative.

Synthetic mimics of antimicrobial peptides with immunomodulatory responses

A new series of aryl-based synthetic mimics of antimicrobial peptides (SMAMPs) with antimicrobial activity and selectivity have been developed via systematic tuning of the aromatic groups and charge. The addition of a pendant aromatic group improved the a